Short answer
Teva Pharmaceutical Industries Ltd (TEVA) filed an 8-K current report with the SEC on September 14, 2026 reporting Item 8.01 (Other Events). NYSE trading shifted from ADSs to ordinary shares under ticker TEVA on September 14, 2026.
Teva Pharmaceutical Industries Ltd 8-K event analysis
AI summary of each reported item and its exhibits
Item 8.01 · Other Events
- NYSE trading shifted from ADSs to ordinary shares under ticker TEVA on September 14, 2026
- ADS program terminated, with each ADS exchanged one-for-one into an ordinary share
- Tel Aviv Stock Exchange listing continues under TEVA
- Investors retain U.S. market access, while the security structure and ADS-related administration change
Generated from the filing text and exhibits; verify against the original. What 8-K item codes mean
Other Teva Pharmaceutical Industries Ltd 8-K filings
Get the next TEVA 8-K as it lands
Follow TEVA for push alerts, or ask the research agent what this filing means.